Alexion Pharmaceuticals Inc (USD)
ALXN
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range110.72 | 114.80
52-Wk Range- | -
Last Close111.74
Mkt Cap (m)24,490.39
Dividend yield-
ISINUS0153511094
Volume2,333,221.00
Exchange VenueNAS

Company Profile

Alexion Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

Key Information
Price/Earning29.80
Price/Book2.33
Price/Sales4.49
P/CF10.12
Rev Growth (3 year avg)17.41
EPS Growth (3 year avg)0.83
Operating Margin % 42.87
Net Margin %48.17
Return on Equity23.53
Debt/Equity0.24

Documents

Prospectus
en 13/08/2015
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.alexion.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)2,233.732,604.053,084.003,551.104,131.204,991.10
Operating Income (m)915.88682.31793.00804.001,594.602,139.90
Net Income (m)656.91144.39399.00443.3077.602,404.30
Basic EPS3.320.681.781.980.3510.77
Avg. Diluted Shares Outstanding (m)201.62215.93227.00225.40224.50224.80
Balance Sheet
USD201420152016201720182019
Current Assets (m)2,796.032,425.352,578.002,953.903,385.005,076.40
Non Current Assets (m)1,405.9310,707.8810,675.0010,629.4010,546.9012,468.20
Total Assets (m)4,201.9613,133.2313,253.0013,583.3013,931.9017,544.60
Current Liabilities (m)606.74718.25823.00952.501,174.001,194.30
Total Liabilities (m)------
Total Equity (m)3,302.028,258.628,694.008,893.109,165.3011,271.80
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)640.08675.201,086.001,115.60426.002,084.90
Capital Expenditure (m)-136.65-286.34-333.00-357.30-213.00-170.70
Figures are quoted in USD unless stated otherwise
2.77 (2.48%)
$
114.51
Last Price